Application of impulse oscillometry in cystic fibrosis patients
https://doi.org/10.18093/0869-0189-2005-0-2-84-88
Abstract
Impulse oscillometry (IOS) measures the total respiratory system impedance (Z) at incremental frequencies during normal tidal breathing.
Our aim was to establish the total respiratory impedance and how IOS measurements relate to conventional lung function indices in patients with cystic fibrosis (CF). Results from spirometry, static lung volumes and IOS (R, X, Z, resonant frequency (FR) and reactance area 5Hz — FR (AX)) were compared in 66 adult CF patients recruited from CF Care Centre of Moscow. Patients had airway obstruction (FEV1 = 57 % pred.), hyperinflation (RV = 253 % pred., FRC = 158 % pred., RV / TLC = 52 %). IOS demonstrated a frequency dependent increase in R (R5 = 173 % pred., R20 = 140 % pred.) and a decrease in X (X5 = –0,23 kPa/L / s) with a shift in FR to higher frequencies (FR = 18 Hz, AX = 1,4 kPa / L). There were significant correlations between FR, X20, R5, R20, AX and conventional lung function indices (FEV1 = – 0,74; 0,78; –0,42; –0,31 and –0,76 respectively). The data indicate that measurement of reactance and FR may reflect the degree of airway obstruction. IOS is an effort independent measurement that could be used in clinical routine especially in patients with severe lung diseases.
About the Authors
A. V. Cherniak
НИИ пульмонологии МЗ и СР РФ
Russian Federation
Russian Federation
E. L. Amelina
НИИ пульмонологии МЗ и СР РФ
Russian Federation
Russian Federation
References
1. Амелина Е.Л., Черняк А.В., Черняев А.Л. Муковисцидоз: определение продолжительности жизни. Пульмонология 2001; 3: 61–64.
2. Капранов Н.И., Каширская Н.Ю. Актуальные проблемы муковисцидоза на современном этапе в России. Пульмонология 1997; 4: 7–17.
3. Сенкевич Н.Ю., Амелина Е.Л. Качество жизни взрослых больных муковисцидозом: факты и гипотезы. Пульмонология 1999; 3: 51–57.
4. Corey M., Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am. J. Epidemiol. 1996; 143: 1007–1017.
5. FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J. Pediatr. 1993; 122: 1–9.
6. Elborn J.S., Shale D.J., Britton J.R. Cystic fibrosis: current survival and population estimates to the year 2000 [published erratum appears in: Thorax 1992; 47 (2): 139]. Thorax 1991; 46: 881–885.
7. Davis P.B. Clinical pathophysiology and manifestations of lung disease. Yankaskas J.R., Knowles M.R., eds. Cystic fibrosis in adult. Philadelphia: Lippincon Raven Publishers; 1999. 45–67.
8. Muller E., Vogel J. Measurement and model interpretation of new parameters of lung mechanics. Z. Erkr. Atmungsorg. 1981; 157: 340–344.
9. American Thoracic Society. Standardization of spirometry. Am. Rev. Respir. Dis. 1987; 136: 1285–1298.
10. European Community for Steel and Coal: standardised lung function testing: lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (suppl. 16): 5–40.
11. Zapletal A., Samanek M., Paul T. Lung function in children and adolescents: methods, reference values. Progr. Respir. Res. 1987; 22: 114–187.
12. Eltayara L., Becklake M.R., Volta C.A., Milic&Emili J. Relationship between chronic dyspnoea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996; 154: 1726–1734.
Review
For citations:
Cherniak A.V., Amelina E.L. Application of impulse oscillometry in cystic fibrosis patients. PULMONOLOGIYA. 2005;(2):84-88. (In Russ.) https://doi.org/10.18093/0869-0189-2005-0-2-84-88
Views:
305
Email this article 